Indian pharmaceutical company Lupin has announced its approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for Obeticholic Acid Tablets, 5 mg and 10 mg. In March 2023, Lupin was issued tentative approval for Obeticholic Acid Tablets, 5 mg and 10 mg from the FDA. These tablets are […]
Lupin said that it has been issued tentative approval for Obeticholic Acid Tablets, 5 mg and 10 mg from the US Food and Drug Administration (FDA). The Indian pharma company approval is for the abbreviated new drug application (ANDA) for marketing a generic version of Intercept Pharmaceuticals’ Ocaliva Tablets, 5 mg and 10 mg. As […]
